Cardio Diagnostics Holdings, Inc. (CDIOW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 6K 12K 18K Q1 '22: 0 Q2 '22: 0 Q3 '22: 0 Q4 '22: 950 Q1 '23: 0 Q2 '23: 1.7K Q3 '23: 10K Q4 '23: 5.3K Q1 '24: 15.9K Q2 '24: 7.9K Q3 '24: 6.6K Q4 '24: 4.5K Q1 '25: 940 Q2 '25: 7.5K Q3 '25: 2.9K Q4 '25: 3.6K Q1 '26: 2.7K Q2 '26: 5.4K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -324 Q4 '21: -144.6K Q1 '22: -227.1K Q2 '22: -787K Q3 '22: -1.2M Q4 '22: -2.4M Q1 '23: -1.7M Q2 '23: -2.6M Q3 '23: -1.4M Q4 '23: -1.5M Q1 '24: -4.2M Q2 '24: -1.3M Q3 '24: -1.4M Q4 '24: -1.5M Q1 '25: -1.6M Q2 '25: -1.7M Q3 '25: -1.7M Q4 '25: -1.5M Q1 '26: -1.8M Q2 '26: -1.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -324 Q4 '21: -144.1K Q1 '22: -290.1K Q2 '22: -842K Q3 '22: -1.2M Q4 '22: -2.4M Q1 '23: -1M Q2 '23: -4M Q3 '23: -1.9M Q4 '23: -1.4M Q1 '24: -4.2M Q2 '24: -1.3M Q3 '24: -1.4M Q4 '24: -1.5M Q1 '25: -1.6M Q2 '25: -1.7M Q3 '25: -1.7M Q4 '25: -1.5M Q1 '26: -1.8M Q2 '26: -1.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -174 Q4 '21: -300.8K Q1 '22: -186.1K Q2 '22: -394.8K Q3 '22: -1.4M Q4 '22: -3.1M Q1 '23: -1.6M Q2 '23: -1.3M Q3 '23: -1M Q4 '23: -1.7M Q1 '24: -1.2M Q2 '24: -1.2M Q3 '24: -1.2M Q4 '24: -1.4M Q1 '25: -1.4M Q2 '25: -1.6M Q3 '25: -1.4M Q4 '25: -1.4M Q1 '26: -1.6M Q2 '26: -1.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q3 '22: -1.4M Q3 '23: -1.1M Q4 '23: -2.2M Q1 '24: -1.3M Q2 '24: -1.4M Q3 '24: -1.2M Q4 '24: -1.4M Q1 '25: -1.4M Q2 '25: -1.6M Q3 '25: -1.6M Q4 '25: -1.4M Q1 '26: -1.6M Q2 '26: -1.3M Q3 '22 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q1 '22: 4.2M Q2 '22: 5.4M Q3 '22: 6.6M Q1 '23: 9.5M Q2 '23: 10.2M Q3 '23: 11.9M Q1 '24: 702.6K Q2 '24: 753.6K Q3 '24: 814.8K Q1 '25: 1.7M Q2 '25: 1.7M Q3 '25: 1.8M Q1 '26: 2.8M Q2 '26: 3M Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.50 -7.00 -3.50 0.00 3.50 7.00 10.50 Q4 '22: -1.49 Q1 '23: -1.53 Q2 '23: -1.76 Q3 '23: -1.75 Q4 '23: -0.66 Q1 '24: -6.48 Q2 '24: -7.80 Q3 '24: -9.37 Q4 '24: -9.65 Q1 '25: -4.69 Q2 '25: -3.95 Q3 '25: -3.20 Q4 '25: -3.72 Q1 '26: -3.38 Q2 '26: -2.92 Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.